Wright, PhD, Harvard Medical School and Harvard Pilgrim Health Care Institute has conducted a retrospective study to assess changes in obesity treatment practices for youth, examining trends in both lifestyle interventions and medication use since the AAP recommendations were introduced
There can be no assurance that the program will achieve its intended technical, clinical, regulatory, or commercial objectives
[1] [2] During this period, you may notice: Rising blood glucose levels as the medication's glucose-lowering effect wanes Increased appetite as the appetite-suppressing properties diminish Potential weight regain if dietary habits have not been modified Return of previous symptoms such as increased thirst or frequent urination The speed and severity of these changes vary considerably between individuals and depend on factors including your baseline diabetes control, concurrent medications, diet, physical activity levels, and the duration of Rybelsus treatment
Handle using standard laboratory practices (clean tools, appropriate PPE, and contamination control) in accordance with institutional requirements